Article Information
History
- February 19, 2014.
Article Versions
- Version 1 (February 17, 2014 - 16:20).
- You are currently viewing Version 2 of this article (February 19, 2014 - 06:41).
- Version 3 (May 28, 2015 - 07:50).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Andrea Ganna1,2,*,
- Tove Fall1,*,
- Woojoo Lee3,
- Corey D. Broeckling4,
- Jitender Kumar1,
- Sara Hägg1,2,
- Patrik K. E. Magnusson2,
- Jessica Prenni4,5,
- Lars Lind6,
- Yudi Pawitan2 and
- Erik Ingelsson1
- 1Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
- 2Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
- 3Department of Statistics, Inha University, Incheon, Korea.
- 4Proteomics and Metabolomics Facility, Colorado State University, Fort Collins, Colorado, USA.
- 5Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, CO, USA.
- 6Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
- Address for correspondence:
Erik Ingelsson, MD, PhD, FAHA, Department of Medical Sciences, Molecular Epidemiology, Uppsala University Hospital, SE-751 85 Uppsala, Sweden, Phone: +46-70-7569422; Fax: +46-18-515570; E-mail: erik.ingelsson{at}medsci.uu.se